The jab, known as mRNA4359 and developed by Moderna, is currently aimed at people with advanced melanoma, lung cancer and other solid tumour cancers.
It is designed to prime the body to recognise and fight cancer cells has shown it could stimulate the immune system to help treat the disease more effectively, according to the results of an early trial.
For the first in-human study of the treatment, 19 patients with advanced solid tumours were given between one and nine doses of mRNA-4359.
Researchers found tumours did not grow and no new tumours appeared in eight of the 16 patients who were evaluated. They also said the treatment was “well tolerated without serious side effects”.
Researchers described the results as “an important first step” in potentially developing a new treatment for people with advanced cancers.
It uses mRNA technology, similar to Covid-19 vaccines, which teaches the immune system how cancer cells differ to healthy cells and mobilises it to destroy them.
Denne historien er fra September 13, 2024-utgaven av The Independent.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra September 13, 2024-utgaven av The Independent.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
It's the unmade Rocky film with a twist... roll up, folks
There is no hate, no love, the gloves are big and the rounds will be short when Mike Tyson and Jake Paul fight on Friday night.
While rivals hit the buffers, Liverpool deserve their lead
Alexis Mac Allister can have a footballing eloquence. His job involves reading the game.
United's ship steadied, now Amorim hits deeper waters
It may be the way all Manchester United managers imagine their reign ending.
Supermarket shoppers will soon find ‘every little hurts'
Is chancellor Rachel Reeves’s decision to hike employers’ national insurance contributions (NICs) about to hit us all – and right in the supermarket baskets?
Barclays warns tax rise will hit workers' living standards
Business leaders accuse government of betraying the nation’
How Gary Barlow became accidental king of memes
The singer is currently enjoying a load of nice days out’ on his new travel show. It’s the latest step in his reinvention as an inadvertent icon of hun culture’, says Katie Rosseinsky
Brothers grim: on the dark world of Nineties boybands
As anew documentary series reveals what it was really like to ride the pop train to stardom, Jessie Thompson remembers her own youthful obsession and looks behind the curtain
Cast iron catnip for Gen Z's aspirations of adulthood
Police had to be called after hundreds of frenzied shoppers descended on a cookware sale this weekend. Helen Coffey dons oven gloves to tackle the LeCreuSlay phenomenon
'Some boys wet themselves, some wanted their mothers'
Reckless exposure to atomic weapons tests left young men and later, their children suffering from debilitating illness and disability. Zoé Beaty reports on the long fight for justice
Why India's trainee doctors are hoping for more bodies
Logistical hurdles and cultural sensitivities are affecting the donation of cadavers, so medical students are forced to train on anatomical models or simulations, reports Namita Singh
